1 palmitoyl 2 stearoyl sn glycero 3 phosphocholine

Manufactured by Avanti Polar Lipids

Sourced in United States

1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine is a synthetic phospholipid compound. It is a key component of cell membranes and can be used in various research and industrial applications.

Automatically generated - may contain errors

Lab products found in correlation

1 2 dioleoyl sn glycero 3 phosphocholine, by Lipoid (1 mentions) 1 2 distearoyl sn glycero 3 phosphocholine, by Lipoid (1 mentions) 1 2 dipalmitoyl sn glycero 3 phosphocholine, by Avanti Polar Lipids (1 mentions) 1 palmitoyl 2 linoleoyl sn glycero 3 phosphocholine, by Avanti Polar Lipids (1 mentions) 1 2 dilinoleoyl sn glycero 3 phosphocholine, by Avanti Polar Lipids (1 mentions) 3 3 dioctadecyloxacarbocyanine perchlorate, by Merck Group (1 mentions) Chloroform chcl3, by Thermo Fisher Scientific (1 mentions) 1 2 dipalmitoyl sn glycero 3 phospho 1 rac glycerol, by Avanti Polar Lipids (1 mentions) 1 2 distearoyl sn glycero 3 phosphoethanolamine, by Avanti Polar Lipids (1 mentions)

2 protocols using 1 palmitoyl 2 stearoyl sn glycero 3 phosphocholine

Phosphatidylcholine: Sourcing and Standards

Check if the same lab product or an alternative is used in the 5 most similar protocols

Phosphatidylcholine type S100 (soybean lecithin, phosphatidylcholine content ≥94%) and S-PC-3 (soybean lecithin, hydrogenated, phosphatidylcholine content ≥98%) were kindly provided by Lipoid GmbH, Ludwigshafen, Germany.
According to the manufacturer’s specification the fatty acids of the two acyl groups of phosphatidylcholine within the used lecithin types are listed in Table 1.
Phosphatidylcholine standards of 1,2-dilinoleoyl-sn-glycero-3-phosphocholine (18:2–18:2 PC, DLPC), 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine (16:0–18:2 PC, PLPC), 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (16:0−18:0 PC, PSPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (16:0–16:0 PC, DPPC) were purchased from Avanti Polar Lipids (Alabama, US). Phosphatidylcholine standards 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (16:0–18:1 PC, POPC), 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1–18:1 PC, DOPC) and 1,2-distearoyl-sn-glycero-3-phosphocholine (18:0–18:0 PC, DSPC) were supplied from Lipoid GmbH (Ludwigshafen, Germany).

Zlomke C., Albrecht J, & Mäder K. (2020). Nicardipine Loaded Solid Phospholipid Extrudates for the Prevention of Cerebral Vasospasms: In Vitro Characterization. Pharmaceutics, 12(9), 817.

+ Open protocol

+ Expand

Lipid Compound Characterization and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lipid compounds including 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (HSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino (polyethyleneglycol)-2000] [DSPE-PEG(2000)], 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol)-2000]-folate [DSPE-PEG (2000)-folate], 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DPPG), and cholesterol were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Free folate; PFP (29°C BP); and fluorescent dyes including 4′,6-diamidino-2-phenylindole (DAPI), 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine iodide (DiR), 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI), and 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO) were purchased from Sigma-Aldrich Chemical Co. (St Louis, MO, USA). Chloroform (CHCl₃) was purchased from Fisher Scientific (Waltham, MA, USA).

Liu J., Shang T., Wang F., Cao Y., Hao L., Ren J., Ran H., Wang Z., Li P, & Du Z. (2017). Low-intensity focused ultrasound (LIFU)-induced acoustic droplet vaporization in phase-transition perfluoropentane nanodroplets modified by folate for ultrasound molecular imaging. International Journal of Nanomedicine, 12, 911-923.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!